Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pd-103 Dose De-Escalation for Early Stage Prostate Cancer: A Prospective Randomized Trial

NCT00247312 is registered in ClinicalTrials.gov with Schiffler Cancer Center as lead sponsor.

NCT NCT00247312
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00247312 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pd-103 Dose De-Escalation for Early Stage Prostate Cancer: A Prospective Randomized Trial
Lead sponsor
Schiffler Cancer Center
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2005
Completion date
November 30, 2015
Enrollment
319 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

prostatic neoplasm